Press Releases.

VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update

Volition Announces Clinical Research Study with Oncovet

Volition to Participate in a Lung Cancer Screening Study in France

VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update

Volition Announces the Launch of the Nu.Q® Vet Cancer Screening Test in the U.S. and Europe Through Heska's Reference Laboratories

Volition Signs Global Supply Agreement for Nu.Q® Vet Cancer Test

Volition Appoints Mickie Henshall as an Independent Director

VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update

Volition Announces U.S. Clinical Study for NETs

VolitionRx Limited Schedules Second Quarter 2022 Earnings Conference Call and Business Update

Volition Appoints DXOCRO to Spearhead U.S. FDA Strategy

VolitionRx Awarded $1.5 Million in Non-Dilutive Funding